HealthEquity, Inc.HQYNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average, slight contraction.
Left:
||||
Year-over-year research & development expense growth
Latest
1.72%
↓ 78% below average
Average (39q)
7.93%
Historical baseline
Range
High:101.90%
Low:-5.44%
CAGR
-4.6%
Modest growth trend
| Period | Value |
|---|---|
| Q4 2025 | 1.72% |
| Q3 2025 | 5.48% |
| Q2 2025 | -4.98% |
| Q1 2025 | 7.42% |
| Q4 2024 | 2.75% |
| Q3 2024 | 4.44% |
| Q2 2024 | 1.54% |
| Q1 2024 | -0.68% |
| Q4 2023 | 1.55% |
| Q3 2023 | 2.96% |
| Q2 2023 | 0.89% |
| Q1 2023 | 7.84% |
| Q4 2022 | 4.96% |
| Q3 2022 | 3.09% |
| Q2 2022 | -1.62% |
| Q1 2022 | 20.64% |
| Q4 2021 | 0.45% |
| Q3 2021 | 6.85% |
| Q2 2021 | 9.75% |
| Q1 2021 | 5.08% |
| Q4 2020 | 0.34% |
| Q3 2020 | -1.36% |
| Q2 2020 | -1.39% |
| Q1 2020 | 34.04% |
| Q4 2019 | 101.90% |
| Q3 2019 | 6.79% |
| Q2 2019 | 9.03% |
| Q1 2019 | 15.26% |
| Q4 2018 | 3.33% |
| Q3 2018 | 5.25% |
| Q2 2018 | 6.67% |
| Q1 2018 | 8.94% |
| Q4 2017 | 1.02% |
| Q3 2017 | 8.89% |
| Q2 2017 | -4.67% |
| Q1 2017 | 5.46% |
| Q4 2016 | 24.35% |
| Q3 2016 | 7.96% |
| Q2 2016 | -5.44% |
| Q1 2016 | 10.68% |